These medications help by: Controlling appetite
BPC-157 targets connective tissue, joints, and the gastrointestinal tract while reducing inflammation
At 6'1" and 183 pounds, Turner, a 44-year-old entrepreneur from Charlotte, North Carolina, with a finance background, wasnt interested in weight loss
However, this does not prove that every symptom during weight loss is caused by toxicant mobilization, and current evidence has not established a unique GLP-1-related toxin release syndrome. Symptoms during GLP-1 treatment are more often explained by recognized medication effects, reduced food or fluid intake, dehydration, constipation, nutrient insufficiency, blood sugar changes, or gallbladder complications
Can Retatrutide Cause Serious or Life-Threatening Side Effects
Coincidentally, some of them were taking GLP-1 medications for weight loss or diabetes